Ironwood Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowe…

Drug Manufacturers - Specialty & Generic
US, Boston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Ironwood Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Ironwood Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Ironwood Pharmaceuticals, Inc..

End of IRWD's Analysis
CIK: 1446847 CUSIP: 46333X108 ISIN: US46333X1081 LEI: - UEI: -
Secondary Listings
IRWD has no secondary listings inside our databases.